国家中医药管理局会同相关部门依法查处两起涉中医药网络违规营销宣传问题1。第一起案件涉及"香港大药房"网店，该店铺销售的"透骨膏"等产品实为日用品而非药品，却进行虚假宣传1。京东、拼多多、小红书、抖音、快手等平台下架店铺35家、违规商品链接3318个、违规广告342条，并拦截违规广告素材460条1。
第二起案件涉及处方药违规推荐，多名医生借网络平台违规推荐处方药"排毒清脂颗粒"，涉及22个医疗机构和27名医生1。两起事件均对消费者权益和中医药行业声誉造成损害，相关违规行为涉嫌违反《中华人民共和国广告法》第十七条1。
The State Administration of Traditional Chinese Medicine, working in coordination with relevant authorities, has taken enforcement action against two cases involving irregular online marketing and promotional practices related to Chinese medicine and pharmaceuticals, according to a notice issued on August 31 1.
In the first case, the "Hong Kong Drugstore" online shop engaged in false promotional claims by selling consumer goods—such as "Penetrating Bone Ointment"—as pharmaceuticals 1. Following investigations, major e-commerce platforms including JD.com, Pinduoduo, Xiaohongshu, Douyin, and Kuaishou removed 35 stores and 3,318 product links containing violations, while intercepting 460 pieces of non-compliant advertising materials and removing 342 non-compliant advertisements 1. These actions have resulted in significant damage to consumer rights and the reputation of the traditional Chinese medicine industry.
The second enforcement case targeted multiple medical practitioners who unlawfully recommended the prescription drug "Detoxification and Fat-Clearing Granules" through online platforms 1. The violation involved 22 medical institutions and 27 doctors 1. Both cases are suspected to violate Article 17 of the Advertising Law of the People's Republic of China 1.
评论
还没有评论，欢迎留下第一条。